INTERNATIONAL PATENT: REVIR THERAPEUTICS, INC., SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. FILES APPLICATION FOR "2-(4-CHLORO-3-FLUOROPHENOXY)-N-[TRANS-4-[5-[3-(TRIFLUOROMETHOXY)-1-AZETIDINYL]-1,3,4-OXADIAZOL-2-YL]CYCLOHEXYL]-ACETAMIDE FOR USE IN THE TREATMENT OF VANISHING WHITE MATTER, HUNTINGTON'S DISEASE, CHARCOT MARIE TOOTH SYNDROME, AMYOTROPHIC LATERAL SCLEROSIS OR FOR INCREASING THE GUANINE NUCLEOTIDE EXCHANGE FACTOR ACTIVIT"

GENEVA, Dec. 2 -- REVIR THERAPEUTICS, INC. (150 North Hill DriveBrisbane, CA 94005), SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (No. C101, 1f, 289 Digital PeninsulaNo.2 Hongliu Rd.Fubao Community, Fubao St., Futian DistrictShenzhen, Guangdong, 518017) filed a patent application (PCT/US2025/030866) for "2-(4-CHLORO-3-FLUOROPHENOXY)-N-[TRANS-4-[5-[3-(TRIFLUOROMETHOXY)-1-AZETIDINYL]-1,3,4-OXADIAZOL-2-YL]CYCLOHEXYL]-ACETAMIDE FOR USE IN THE TREATMENT OF VANISHING WHITE MATTER, HUNTINGTON'S DISEASE, CHARCOT MARIE TOOTH SYNDROME, AMYOTROPHIC LATERAL SCLEROSIS OR FOR INCREASING THE GUANINE NUCLEOTIDE EXCHANGE FACTOR ACTIVIT" on May 23, 2025. With publication no. WO/2025/245500, the details related to the patent application was published on N...